Although these existing indirect evidence was tempting to conclude that ALA had effect on regulation of mTOR signaling, regulation of the mTOR pathway by ALA in immune cells is worthy of further investigation for patients with autoimmune diseases of high relapse rate and poor responsiveness to traditional treatment. The gene discussed is MTOR; the disease is autoimmune disease.